Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Skip to article
Contents · Peripheral SpA
Chapter 6 · Diagnosis and phenotyping

Differential Diagnosis and Important Mimics

Prioritize dangerous and plausible alternatives to peripheral SpA by the presenting problem: hot joint, persistent synovitis, enthesis pain or swollen digit.

Open accessEvidence reviewed:
On this page

Start with the problem that must be explained

“Could this be SpA?” is only half the diagnostic task. The other half is whether infection, crystals, another inflammatory arthritis or a noninflammatory process explains the presentation better—or coexists with SpA. Organize the differential around the current lesion and its tempo rather than a long undirected list.

First decide whether the problem is joint-centered, periarticular, whole-digit or more diffuse. Then establish onset, objective inflammation, systemic features, exposure history and the consequences of missing an alternative. A known rheumatic diagnosis can increase the risk of premature closure, particularly when immunosuppression changes the presentation of infection.

Acute monoarthritis or oligoarthritis: infection comes first

A new hot swollen joint requires prompt evaluation for septic arthritis. Fever may be absent. When infection is suspected, obtain joint fluid urgently for microbiology, cell count and crystal analysis; sepsis requires immediate management without delaying antibiotics for a sampling procedure. Neither a low synovial leukocyte count nor crystals safely excludes concomitant infection. These principles are emphasized in SANJO guidance. [1]

Ask about recent procedures, wounds, injection, bacteremia, prosthetic material, immunosuppression and relevant exposures. The diagnostic urgency comes from the clinical risk, not whether an inflammatory disease code is already in the chart. An apparent “flare” in one unusual joint deserves its own explanation.

Crystal disease can look inflammatory because it is inflammatory

Gout and calcium pyrophosphate disease can cause abrupt attacks, recurrent oligoarthritis or persistent inflammation. Serum urate does not establish the cause of an acutely swollen joint, and a normal value during an attack does not reliably settle the question. Use the overall phenotype, aspiration when indicated and appropriate imaging.

EULAR crystal-imaging recommendations describe roles for ultrasound and dual-energy CT in gout and radiography or ultrasound in CPPD. They also stress that imaging deposits may be clinically silent. [2] A deposit at one site does not prove that every current symptom is crystal-related. Likewise, convincing crystal imaging does not remove the need to evaluate possible joint infection.

Persistent synovitis: revisit RA, PsA and other inflammatory disease

Persistent small-joint synovitis, evolving symmetry and an erosive pattern may require a rheumatoid arthritis pathway. RF and anti-CCP can modify probability, but neither a negative result nor a positive low-titer test replaces the phenotype. The 2010 RA framework itself requires inflammatory synovitis without a better explanation before its score is applied. [3]

Look deliberately for psoriasis and nail disease when the pattern suggests PsA. Skin manifestations may be subtle, historical or treated. Inflammatory arthritis without current psoriasis is not automatically non-psoriatic pSpA, and a patient with psoriasis may also develop RA, gout or another cause of pain. Select testing to adjudicate the specific alternatives rather than using a broad autoimmune panel.

Systemic features may direct evaluation toward connective-tissue disease, sarcoidosis, vasculitis or another inflammatory condition. The threshold for targeted work-up should be driven by the actual findings: rash pattern, cytopenia, organ injury, neuropathy, pulmonary features or constitutional change. A SpA-associated symptom is not an exemption from those pathways.

Enthesis-predominant pain: locate the lesion before naming it

Mechanical tendinopathy, insertional degeneration, bursitis, partial tear, nerve entrapment and referred pain can all mimic an inflammatory attachment-site problem. A sudden increase in load or a local injury can be highly relevant even when SpA is established. Conversely, a mechanical contributor does not exclude superimposed inflammation.

Inspect gait and local mechanics, compare sides, examine the tendon body and adjacent bursa, and assess focal weakness or a defect where appropriate. Widespread tenderness, poor sleep and sensitization can increase the clinical tenderness count. Such findings do not make pain unreal, but they change what can reasonably be inferred from palpation.

When ultrasound is used, ask whether there is active inflammatory signal, structural change, a tear or another lesion. A heel spur or thickened tendon alone is insufficient to declare active inflammatory enthesitis. A technically negative study is also not an explanation for all pain; the next step is to reassess the anatomical and clinical question.

Dactylitis-like swelling: several tissues, several causes

Diffuse digit swelling can occur with psoriatic or other SpA inflammation, but infection, crystal disease, trauma and less common infiltrative or granulomatous processes may resemble it. Examine for wounds, focal tendon-sheath tenderness, skin changes, fever and vascular or neurologic compromise. A rapid, severe or atypical presentation should not be placed into a chronic inflammatory pathway solely because the digit looks familiar.

Clarify whether the swelling involves the entire digit or only one joint. Ultrasound or MRI may identify the dominant tissue problem when examination is insufficient, but a scan should not delay urgent evaluation of suspected infection. Persistent unexplained enlargement also warrants reconsideration rather than indefinite treatment as a flare.

Pain disproportionate to inflammatory findings

Osteoarthritis, structural damage, altered mechanics, hypermobility, neuropathic pain and nociplastic mechanisms may contribute to disability. Several may coexist. Compare pain distribution and triggers with swelling, function, biomarkers and targeted imaging. The goal is to build an explanation that accounts for the whole pattern, not to force every symptom into one mechanism.

Neither a normal CRP nor a quiet examination alone proves absence of inflammatory disease. Equally, historical inflammation does not prove that escalating immunosuppression will treat today’s pain. State which findings support current inflammation, which do not, and what further observation would resolve the uncertainty.

A problem-based reassessment table

PresentationPriority alternativesUseful next question
New hot jointInfection, gout, CPPDDoes this require immediate aspiration and infection management?
Persistent small-joint swellingRA, PsA, other inflammatory arthritisIs the distribution and serology more consistent with a different disease?
Focal heel painTendinopathy, tear, bursitis, mechanical loadWhich structure is abnormal, and is inflammation actually supported?
Whole-digit swellingSpA, infection, crystals, injuryWhat is the tempo and which tissues are involved?
High pain with low inflammatory burdenDamage, mechanics, neuropathic or nociplastic painWhich mechanism explains the functional loss and deserves treatment?

Make uncertainty actionable

A useful assessment names the leading explanation, the dangerous alternative that has been addressed, and the most plausible remaining competitor. Specify the next test or observation and what each result would change. Early-arthritis guidance supports clinical examination and targeted investigation rather than diagnosis by a laboratory panel. [4]

Revisit the differential after an unexpected course, new organ finding, repeated treatment failure or a mismatch between symptoms and objective inflammation. The purpose is not to relabel at every visit. It is to prevent an old label from becoming an obstacle to better care.

Evidence in context

Source status checked October 6, 2026. Population applicability and publication maturity are separate judgments.

Scrollable evidence table

SourcePopulation and phenotypeDesign and statusApplicabilityClinical implicationImportant limitationLast checked
SANJO [1]Suspected native-joint infectionGuideline; peer-reviewedDirect to urgent differentialAspiration and microbiology are centralNo single clinical or fluid cutoff excludes infection2026-10-06
Crystal imaging [2]Gout, CPPD and basic calcium phosphate diseaseGuideline; peer-reviewedAlternative disease contextUse disease-specific imaging appropriatelyDeposits can be asymptomatic; infection can coexist2026-10-06
RA criteria [3]Inflammatory synovitisClassification initiative; peer-reviewedAlternative inflammatory diagnosisExclude a better explanation before scoringClassification is not individual diagnosis2026-10-06
Early arthritis [4]Early inflammatory arthritisGuideline; peer-reviewedGeneral diagnostic workflowClinical findings guide targeted testsNot specific to SpA2026-10-06

Sources

  1. Ravn et al. SANJO guideline for septic arthritis in native joints (2023)
  2. Mandl et al. 2023 EULAR imaging recommendations for crystal-induced arthropathies
  3. Aletaha et al. 2010 ACR/EULAR rheumatoid arthritis classification criteria
  4. Combe et al. 2016 update of EULAR early arthritis recommendations

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: Peripheral SpASpondyloarthritis